ISSN: 1758-2024

Journal Home

Journal Guideline

Neurodegenerative disease management Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neurodegenerative disease management is a journal indexed in SJR in Neurology (clinical) with an H index of 36. It has an SJR impact factor of 0,896 and it has a best quartile of Q2. It has an SJR impact factor of 0,896.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Neurology (clinical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,896

SJR Impact factor

36

H Index

26

Total Docs (Last Year)

106

Total Docs (3 years)

1157

Total Refs

311

Total Cites (3 years)

99

Citable Docs (3 years)

2.95

Cites/Doc (2 years)

44.5

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Neural Plasticity Q2
CNS Spectrums Q2
Journal of Geriatric Psychiatry and Neurology Q2
Neurology International Q2
Journal of Neuromuscular Diseases Q2

Compare this journals

Aims and Scope

Best articles by citations

Alexithymia in Parkinson's disease: a point of view on current evidence

Mild cognitive impairment definitions: more evolution than revolution

Journal Watch

Introducing Volume 9 ofNeurodegenerative Disease Management

Nutritional management of individuals with Huntington's disease: nutritional guidelines

Care considerations for dementia in people with Down's syndrome: a management perspective

Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management

Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management.

Deep brain stimulation for Parkinson's disease: current status and future outlook

Depression in the early stages of Huntington disease

Could miRNA expression changes be a reliable clinical biomarker for Parkinson's disease?

New tools for the evaluation of patients with neurodegenerative diseases

SHOW MORE ARTICLES

Cognitive remediation to enhance mobility in older adults: the CREM study

IPX066: a new intermediate- and extended-release carbidopa-levodopa formulation

Diagnostic evaluation and monitoring of patients with posterior cortical atrophy

Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis

Outcome measurement in neurodegenerative disease: attributes, applications & interpretation

The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis

Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening

Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians

Defining premotor Parkinson's disease: a window of opportunity for neuroprotection?

Unpredictable sensations: can stochastic resonance help in Parkinson's disease?

Depression versus dementia: is this construct still relevant?

Neurophysiology in Huntington's disease: an update